NCT04794322: Developing a Test for the Detection of Ovarian Cancer |
|
|
| Recruiting | N/A | 250 | US | Uterine lavage, or a wash of the womb, Blood sample, Pap smear | Massachusetts General Hospital, Johns Hopkins University, Fred Hutchinson Cancer Center, Anne Arundel Health System Research Institute, University of Arkansas, National Cancer Institute (NCI), Kaiser Permanente, McGill University, M.D. Anderson Cancer Center, Swedish Medical Center, TwinStrand Biosciences | Ovarian Neoplasms, Ovarian Epithelial Carcinoma, Fallopian Tube Neoplasms, High Grade Ovarian Serous Adenocarcinoma, Stage I Ovarian Cancer, Stage II Ovarian Cancer, Stage III Ovarian Cancer AJCC v8, Stage IIIA Ovarian Cancer AJCC v8, Stage IIIA1 Ovarian Cancer AJCC v8, Stage IIIA2 Ovarian Cancer AJCC v8, Stage IIIB Ovarian Cancer AJCC v8, Stage IIIC Ovarian Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8 | 03/23 | 03/25 | | |